Actively Recruiting

Age: 18Years - 40Years
All Genders
Healthy Volunteers
ID05122728

Post-Concussion Neuromuscular Function and Musculoskeletal Injury Risk Observational Study in Service Members and Civilians

Led by Walter Reed National Military Medical Center · Updated on 2026-01-27

148

Participants Needed

3

Research Sites

52 weeks

Total Duration

On this page

Sponsors

W

Walter Reed National Military Medical Center

Lead Sponsor

W

Womack Army Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI), especially concussions, are common and serious issues affecting military Service Members and physically active civilians. This research aims to identify how neuromuscular control changes after concussion may increase the risk of MSKI. The study will compare individuals who have had a concussion with those who have not, to understand the reasons behind this increased injury risk and help develop targeted prevention strategies. Participants will undergo detailed assessments including dynamic movement tests like jump-landing, single leg hop, anticipated cut, and gait tasks, along with strength and muscle activation tests. Sensory evaluations will assess proprioception and light touch sensation. These assessments occur at three time points: within 5 days of becoming asymptomatic post-concussion, then at 6 and 12 weeks after the initial assessment. Both concussed and matched non-concussed participants will complete the same testing and self-report psychosocial measures. During the study, participants will report any new musculoskeletal injuries and complete monthly questionnaires for about one year. Researchers will track changes in movement, muscle function, sensory abilities, and patient-reported outcomes over time. The study also monitors psychological factors such as anxiety, depression, and pain interference. This comprehensive approach will help measure how neuromuscular control evolves after concussion and its connection to injury risk.

CONDITIONS

Brief Title

Post-Concussion Musculoskeletal Injury Risks

Who Can Participate

Age: 18Years - 40Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 40 years old.
  • For concussed group: self-reported asymptomatic after concussion and diagnosed within 5 days prior to enrollment.
  • Access to a functional email address and internet for completing questionnaires.
  • For non-concussed group: active duty Service Members or physically active civilians with no concussion in past 5 years.
  • Matched to concussed participants by gender, age (within 2 years), height, weight, body mass index (within 5%), and physical activity type and duration.
Not Eligible

You will not qualify if you...

  • Unable to read or understand English.
  • Hospitalized following concussion.
  • Concussion not caused by physical activity (e.g., blast injury, fall, motor vehicle accident).
  • Loss of consciousness longer than 30 minutes.
  • Altered consciousness longer than 24 hours.
  • Post-traumatic amnesia lasting more than 1 day.
  • Glasgow Coma Scale score below 13.
  • Abnormal brain imaging findings.
  • Took longer than 21 days to become asymptomatic after concussion.
  • Musculoskeletal injury in last 6 months causing missed or altered physical activity for 3 or more days.
  • History of musculoskeletal injury surgery.
  • Pregnant females (eligible after medical clearance post-pregnancy).
  • Contraindications for electrical stimulation including active deep vein thrombosis, infections, malignancy, skin disease, or implanted electronic devices or materials.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Neuromuscular and Biomechanical Assessments

Duration - Initial visit plus follow-up assessments at 6 weeks and 12 weeks post-initial assessment (±72 hours)

Participants complete comprehensive neuromuscular, biomechanical, sensory, and psychosocial assessments to evaluate neuromuscular control and musculoskeletal injury risk following concussion.

3 visits (in-person) at initial, 6 weeks, and 12 weeks

Monthly Self-Reported Outcome Monitoring

Duration - Up to 1 year

Participants self-report musculoskeletal injuries and complete psychosocial questionnaires monthly to monitor changes over approximately one year following the initial assessment.

Monthly remote assessments via email or internet

Trial Site Locations

Total: 3 locations

1

University of Georgia

Athens, Georgia, United States, 30602

Actively Recruiting

2

Walter Reed National Military Medical Center

Bethesda, Maryland, United States, 20814

Actively Recruiting

3

Womack Army Medical Center

Fort Bragg, North Carolina, United States, 28310

Active, Not Recruiting

Loading map...

Research Team

B

Bradford D Hendershot, PhD

J

Joseph G Wasser, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Patient Sponsored Ongoing Open-label Single-arm, Safety an...

Musculoskeletal Injury

Actively Recruiting

1 location

Musculoskeletal Resiliency and Adaptation to Sex Steroid Sup...

Musculoskeletal Injury

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Investigating post-mild traumatic brain injury neuromuscular function and musculoskeletal injury risk: A protocol for a prospective, observational, case-controlled study in service members and active individuals.

Robert C Lynall, Joseph G Wasser, Daniel I Brooks...

https://pubmed.ncbi.nlm.nih.gov/36948547